Testicular Neoplasms

Testicular neoplasms encompass a diverse group of tumors arising from the various cell types found within the canine testicle. The testicle is a complex organ containing germ cells responsible for sperm production, Sertoli cells that provide structural and nutritional support within the seminiferous tubules, and interstitial cells of Leydig that produce testosterone and other androgens. Each of these cell populations can undergo neoplastic transformation, giving rise to the three principal categories of testicular tumors: germ cell tumors (seminomas), sex cord-stromal tumors (Sertoli cell tumors), and interstitial cell tumors (Leydig cell tumors).

Testicular neoplasms are among the most frequently diagnosed tumors in intact male dogs, with prevalence rates estimated at 16 to 27 percent in some necropsy studies of older intact males. The high prevalence is partly attributable to the fact that many testicular tumors are clinically silent and discovered incidentally during necropsy or during castration performed for unrelated reasons. Clinically significant tumors that produce symptoms or hormonal effects represent a smaller subset of the total cases.

The biological behavior of testicular neoplasms spans a wide spectrum, from entirely benign nodules that produce no clinical effects to malignant tumors capable of metastasis and life-threatening paraneoplastic syndromes. Understanding the histological classification, biological behavior, and clinical implications of each tumor type is essential for veterinary practitioners managing intact male dogs and for owners making informed decisions about their dogs' reproductive health.

Multiple concurrent testicular neoplasms are remarkably common in dogs, with studies reporting that 30 to 50 percent of dogs with testicular tumors harbor more than one tumor type, either in the same testicle or in both testicles. This high rate of multiplicity distinguishes canine testicular neoplasia from the human condition and has implications for diagnostic evaluation, as the clinical presentation may reflect the combined effects of multiple tumor types with different hormonal activities.

Sertoli cell tumors are sex cord-stromal neoplasms arising from the sustentacular cells of the seminiferous tubules. These tumors represent approximately one-third of all testicular neoplasms in dogs and are the most clinically significant tumor type due to their frequent association with estrogen production and their relatively higher metastatic potential compared to other testicular tumors. Sertoli cell tumors are disproportionately common in cryptorchid testicles, where they account for the majority of neoplasms diagnosed.

Grossly, Sertoli cell tumors present as firm, lobulated, white to gray masses that may partially or completely replace the normal testicular parenchyma. Larger tumors often contain areas of hemorrhage, necrosis, or cystic degeneration. The tumor surface on cut section typically shows a characteristic whorled or trabecular pattern. In cryptorchid testicles, Sertoli cell tumors may grow to substantial size before detection, as the abdominal or inguinal location shields them from routine palpation.

Histologically, Sertoli cell tumors exhibit several recognized growth patterns, including intratubular, diffuse, and pseudoadenomatous arrangements. The tumor cells are typically elongated or columnar with pale cytoplasm and indistinct cell borders, arranged in cords, tubules, or sheets separated by fibrous stroma. The degree of cellular atypia and mitotic activity varies and may correlate with biological behavior, though the relationship between histological grade and clinical outcome is less well-defined than in some other tumor types.

The metastatic rate for Sertoli cell tumors is approximately 10 to 15 percent, with metastasis occurring via lymphatic drainage to the sublumbar lymph nodes and subsequently to distant sites including the lungs, liver, and other abdominal organs. Factors associated with increased metastatic risk include large tumor size, high mitotic index, evidence of vascular invasion on histopathology, and location within a cryptorchid testicle. Dogs with metastatic Sertoli cell tumors may present with enlarged sublumbar lymph nodes detectable on rectal examination or abdominal imaging.

The endocrine effects of Sertoli cell tumors are their most distinctive clinical feature. Estrogen production by tumor cells creates a state of hyperestrogenism that can produce feminization, bilateral symmetrical alopecia, gynecomastia, prostatic squamous metaplasia, and bone marrow suppression. Not all Sertoli cell tumors are hormonally active, however, and the degree of estrogen production does not always correlate with tumor size or histological appearance.

Seminomas are germ cell neoplasms originating from the spermatogonial cells within the seminiferous tubules. They are the canine counterpart of classical seminomas in human males and share many histological and biological similarities with their human equivalent. Seminomas account for approximately one-third of canine testicular neoplasms and occur in both normally descended and cryptorchid testicles, though they are overrepresented in cryptorchid gonads relative to their frequency in scrotal testicles.

On gross examination, seminomas appear as soft, bulging, homogeneous masses that are typically gray to white in color with a smooth, lobulated cut surface. They tend to be well-demarcated from surrounding normal testicular tissue, though they may become quite large and replace the majority of the testicular parenchyma in advanced cases. Areas of hemorrhage and necrosis may be present in larger tumors, and cystic degeneration occasionally occurs.

The histological appearance of canine seminomas is characterized by sheets, nests, or cords of large, round to polygonal cells with abundant clear to faintly eosinophilic cytoplasm and prominent central nuclei with conspicuous nucleoli. A variable lymphocytic infiltrate is commonly present within the tumor stroma, a feature that parallels human seminomas and may reflect an immune response to tumor antigens. Two histological subtypes are recognized: the classical (typical) seminoma and the spermatocytic seminoma, with the latter being less common and generally carrying a more favorable prognosis.

The metastatic rate for canine seminomas is generally reported to be below 10 percent, making them less aggressive than Sertoli cell tumors in most cases. When metastasis does occur, it typically involves the regional sublumbar lymph nodes initially, with subsequent spread to distant organs. Spermatocytic seminomas are considered virtually non-metastatic. The overall favorable biological behavior of most seminomas contributes to the excellent prognosis following castration.

While seminomas are less commonly associated with endocrine effects than Sertoli cell tumors, a subset of seminomas does produce estrogen or other hormones that can cause feminization and its associated complications. Some reports suggest that the incidence of hormonally active seminomas may be higher than historically recognized, and clinicians should consider seminoma as a potential cause of hyperestrogenism even when a Sertoli cell tumor is not identified grossly.

Interstitial cell tumors, also termed Leydig cell tumors, arise from the testosterone-producing interstitial cells located in the connective tissue between the seminiferous tubules. These tumors are the most common testicular neoplasm found in older intact male dogs and are frequently discovered as incidental findings during necropsy or histopathological examination of castration specimens. Despite their high prevalence, interstitial cell tumors are the least clinically significant of the three major testicular tumor types due to their almost universally benign behavior.

Grossly, interstitial cell tumors are typically small, well-circumscribed, soft to moderately firm nodules that are yellow to orange-brown in color, reflecting their lipid-rich cellular composition. They are often multiple, and bilateral involvement is common. Many interstitial cell tumors are less than two centimeters in diameter and may not produce visible or palpable enlargement of the affected testicle. Larger tumors can occur but are less common, and hemorrhagic or necrotic changes are infrequent.

Histologically, interstitial cell tumors are composed of polygonal cells arranged in sheets, packets, or cords, with abundant eosinophilic to vacuolated cytoplasm containing lipid droplets. The cells bear a close morphological resemblance to normal interstitial cells, and well-differentiated tumors may be difficult to distinguish from nodular hyperplasia of the interstitial cell population, a common age-related change in intact male dogs. Features that favor a diagnosis of neoplasia over hyperplasia include compression of adjacent testicular parenchyma, larger size, and the presence of a fibrous capsule.

Metastasis from interstitial cell tumors is exceptionally rare, with reported rates typically below one percent. This favorable biological behavior means that castration is curative in virtually all cases, and additional staging or treatment is generally unnecessary. The rare case reports of metastatic interstitial cell tumors involve atypical histological features such as high mitotic rates, cellular pleomorphism, and vascular invasion, suggesting that these represent a distinct subset of biologically aggressive variants.

Interstitial cell tumors may produce testosterone, other androgens, or rarely estrogen, though clinically significant hormonal effects are uncommon. When hormonal production does occur, it is typically modest and may not produce overt clinical signs. Occasionally, dogs with functional interstitial cell tumors may show signs of androgen excess, including perineal gland hyperplasia, perianal adenomas, or prostatic hyperplasia. These hormonal effects resolve following castration.

Beyond the three common testicular tumor types, several uncommon and rare neoplasms can arise within the canine testicle. While these tumors are infrequently encountered in clinical practice, awareness of their existence is important for accurate histopathological diagnosis and appropriate clinical management, as some carry more aggressive biological behavior than the common tumor types.

Embryonal carcinomas are highly malignant germ cell tumors that occur rarely in dogs. These tumors are composed of primitive, undifferentiated cells that recapitulate early embryonic tissue and typically exhibit aggressive growth patterns with high mitotic rates and frequent necrosis. The metastatic potential of embryonal carcinomas is significantly higher than that of seminomas, and affected dogs may present with advanced disease at the time of diagnosis. Treatment with castration alone may be insufficient, and adjuvant chemotherapy should be considered.

Teratomas are germ cell tumors containing tissues derived from two or more embryonic germ layers, including ectoderm, mesoderm, and endoderm. In dogs, testicular teratomas are rare and may contain recognizable structures such as cartilage, bone, skin, hair, neural tissue, and glandular epithelium. Most canine testicular teratomas are benign (mature teratomas), though immature teratomas containing embryonal or fetal-type tissues may exhibit more aggressive behavior. Teratomas are more commonly found in cryptorchid testicles.

Gonadoblastomas are mixed neoplasms containing both germ cell and sex cord-stromal elements. These tumors are extremely rare in dogs and are typically associated with disorders of sexual development or intersex conditions. The clinical significance of gonadoblastomas lies in their potential to give rise to more aggressive tumor types, particularly invasive germ cell tumors, necessitating complete surgical excision and careful histopathological evaluation.

Testicular lymphoma can occur as part of multicentric lymphoma or rarely as a primary testicular neoplasm. When the testicle is a site of lymphomatous involvement, the prognosis is generally poor due to the systemic nature of the disease. Primary testicular lymphoma may present as unilateral or bilateral testicular enlargement and can be difficult to distinguish from other testicular tumors on imaging alone, requiring fine-needle aspiration cytology or excisional biopsy for definitive diagnosis. Treatment follows standard lymphoma chemotherapy protocols rather than the surgical approach used for other testicular tumors.

Cryptorchidism is unquestionably the most important predisposing factor for testicular neoplasia in dogs, and the relationship between retained testicles and tumor development has been extensively documented in the veterinary literature. A cryptorchid testicle has an estimated 10 to 14 times greater risk of developing a neoplasm compared to a normally descended scrotal testicle, making cryptorchidism the single most significant risk factor for testicular neoplasms in dogs.

The pathophysiology linking cryptorchidism to increased tumor risk involves several mechanisms. The most widely cited is the effect of elevated temperature on testicular tissue. Normal spermatogenesis requires a temperature two to three degrees below core body temperature, which is achieved by the scrotal location and the thermoregulatory mechanisms of the pampiniform plexus and cremaster muscle. A cryptorchid testicle, whether inguinally or abdominally retained, is exposed to higher temperatures that disrupt normal cellular processes, promote genetic instability, and create a microenvironment conducive to neoplastic transformation.

The distribution of tumor types differs between cryptorchid and normally descended testicles. Sertoli cell tumors and seminomas are markedly overrepresented in cryptorchid testicles, while interstitial cell tumors are rare in undescended gonads. This differential susceptibility likely reflects the distinct responses of different testicular cell populations to the altered physiological environment within a cryptorchid testicle. The germ cells and Sertoli cells, which are most affected by the temperature-related disruption of normal function, appear to be more susceptible to neoplastic transformation in the cryptorchid state.

Abdominally retained testicles carry a higher tumor risk than inguinally retained testicles, which in turn carry a higher risk than normally descended testicles. This gradient of risk correlates with the degree of temperature elevation, with abdominal testicles exposed to the highest temperatures. Additionally, abdominally retained cryptorchid tumors tend to present at a more advanced stage, as they are not detectable by external palpation and may grow substantially before causing clinical signs such as abdominal distension or hormonal effects.

The strong association between cryptorchidism and testicular neoplasia forms the basis for the universal veterinary recommendation that all cryptorchid dogs undergo castration, including surgical retrieval of the retained testicle. This recommendation applies regardless of breed, intended use, or owner preference for maintaining intact status. Furthermore, because cryptorchidism is a heritable condition with a suspected autosomal recessive or polygenic inheritance pattern, affected dogs should not be used for breeding even if the cryptorchid testicle is removed, as they will continue to transmit the genetic predisposition to their offspring.

Histopathological examination of excised testicular tissue is the definitive method for diagnosing and classifying testicular neoplasms in dogs. While clinical examination, imaging, and cytological evaluation can raise suspicion for specific tumor types, accurate classification requires assessment of tissue architecture, cellular morphology, and growth patterns that are only available through standard histological preparation and microscopic examination.

Proper specimen handling begins at the time of surgery. The excised testicle should be incised longitudinally to allow adequate fixative penetration and placed in ten percent neutral buffered formalin at a volume ratio of at least ten parts fixative to one part tissue. For larger tumors, additional incisions through the tumor mass facilitate fixation and reduce the risk of autolytic changes that can compromise histological interpretation. The specimen should be clearly labeled with patient identification and whether it represents the right or left testicle.

Histological evaluation by a veterinary pathologist encompasses several key features that guide diagnosis and prognostication. Cell of origin is determined by morphological characteristics including cell shape, cytoplasmic features, nuclear characteristics, and growth pattern. Growth patterns such as intratubular, diffuse, solid, cystic, or papillary provide additional diagnostic information and may have prognostic significance. The degree of cellular atypia, including nuclear pleomorphism, chromatin pattern abnormalities, and nucleolar prominence, helps assess the level of differentiation.

Mitotic index, defined as the number of mitotic figures per unit area of tumor, is an important prognostic parameter for all testicular tumor types. Higher mitotic rates generally correlate with more aggressive biological behavior and increased metastatic potential. The presence of lymphovascular invasion, in which tumor cells are identified within blood vessels or lymphatic channels, is a particularly ominous histological finding that strongly suggests metastatic capability and warrants more aggressive staging and follow-up.

Immunohistochemistry can be a valuable adjunct to routine histological examination, particularly in cases where the tumor type is ambiguous based on morphology alone. Antibodies directed against specific cellular markers such as placental alkaline phosphatase for germ cell tumors, inhibin for sex cord-stromal tumors, and vimentin for interstitial cell tumors can help confirm the cell of origin. These specialized staining techniques are especially useful for undifferentiated tumors, mixed tumors, and metastatic deposits where the primary tumor type is uncertain.

The endocrine consequences of testicular neoplasms represent one of the most clinically important aspects of these tumors and can produce systemic effects that dramatically impact the affected dog's health and appearance. The testicle is an endocrine organ, and neoplastic transformation of its hormone-producing cells can lead to unregulated production of estrogens, androgens, or other steroid hormones that disrupt the body's normal hormonal equilibrium.

Estrogen overproduction is the most clinically significant endocrine disturbance associated with testicular neoplasms. While Sertoli cell tumors are the most frequent source of excess estrogen, seminomas and rarely interstitial cell tumors can also produce this hormone. The enzyme aromatase, which converts androgens to estrogens, may be upregulated in neoplastic testicular cells, leading to increased estrogen synthesis even when the total androgen production remains within normal limits. The resulting hyperestrogenism produces effects on multiple target organs and tissues.

The dermatological manifestations of hyperestrogenism are often the first signs noticed by owners. Estrogen excess causes telogen effluvium, a non-inflammatory alopecia in which hair follicles prematurely enter the resting phase and hair shafts are subsequently shed without replacement. The hair loss is characteristically bilateral and symmetrical, affecting the perineum, flanks, ventral abdomen, and chest while typically sparing the head and distal extremities. The skin in affected areas may become thin, hyperpigmented, and slightly waxy in texture.

The hematological consequences of chronic hyperestrogenism are potentially life-threatening and warrant particular attention. Estrogen at supraphysiological concentrations exerts a biphasic effect on bone marrow, initially stimulating hematopoiesis before progressing to marrow suppression with prolonged exposure. The resulting pancytopenia affects all three blood cell lineages, producing anemia from decreased erythropoiesis, leukopenia with increased susceptibility to infections, and thrombocytopenia with impaired hemostatic function. Severe aplastic anemia from estrogen toxicity carries a guarded to poor prognosis even with removal of the estrogen source.

Beyond estrogen effects, some testicular neoplasms may produce other hormones or bioactive substances that contribute to paraneoplastic syndromes. Excessive androgen production, primarily from interstitial cell tumors, can cause prostatic hyperplasia, perianal gland adenomas, and behavioral changes. Anti-Mullerian hormone and inhibin may be secreted by Sertoli cell tumors and can serve as serum tumor markers. Understanding the hormonal profile of a testicular neoplasm helps predict its clinical effects and guides monitoring during the post-castration recovery period.

Surgical castration remains the cornerstone of treatment for all testicular neoplasms in dogs, and the technique employed depends on the location of the affected testicle, the size of the tumor, and whether concurrent conditions require attention during the same anesthetic event. Regardless of whether one or both testicles are visibly affected, bilateral orchiectomy is the standard recommendation, as the remaining testicle may harbor microscopic neoplastic foci or may be at increased risk for future tumor development.

For tumors involving normally descended scrotal testicles, the standard prescrotal approach provides excellent access for routine castration. The incision is made on the ventral midline just cranial to the scrotum, and each testicle is exteriorized through the incision. In cases of large tumors that exceed the diameter of the standard incision, the surgical approach may need modification, including enlargement of the incision or a direct scrotal approach with scrotal ablation. When the tumor is very large, care must be taken to identify and ligate the testicular vessels and spermatic cord securely before transection.

Inguinal cryptorchid testicles are approached through an incision over the inguinal ring, where the retained testicle and associated structures can be identified and exteriorized. The inguinal approach allows direct visualization and is generally straightforward, though the anatomical relationships may be distorted when a large tumor has developed within the inguinally retained testicle. The contralateral normally descended testicle is removed through the standard prescrotal incision during the same procedure.

Abdominal cryptorchid testicles require either a ventral midline celiotomy or a laparoscopic approach for identification and removal. Open celiotomy provides the most complete access for exploration of the abdominal cavity, identification of the retained testicle, and assessment of regional lymph nodes and other abdominal organs for evidence of metastatic disease. Laparoscopic castration offers the advantages of reduced tissue trauma, smaller incisions, and typically faster recovery, but may be limited by the size of the tumor and the need for thorough staging evaluation.

Postoperative care following castration for testicular neoplasia includes standard incisional monitoring, activity restriction during the healing period, and pain management as needed. For dogs with estrogen-induced bone marrow suppression, the postoperative period requires intensive supportive care including serial complete blood count monitoring, blood transfusions for severe anemia, platelet support for significant thrombocytopenia, and prophylactic or therapeutic antimicrobial therapy for neutropenic patients. The recovery of bone marrow function following removal of the estrogen source is variable and may require weeks to months of monitoring and support.

Appropriate post-treatment monitoring for dogs that have undergone castration for testicular neoplasms depends on the histological type, grade, and stage of the tumor. For dogs with benign interstitial cell tumors or low-grade seminomas with no evidence of metastasis, routine veterinary care with periodic physical examinations is generally sufficient. More aggressive tumor types, particularly Sertoli cell tumors with adverse histological features, warrant a structured follow-up protocol.

For dogs with potentially malignant testicular neoplasms, a recommended follow-up schedule includes clinical examination and abdominal palpation at one, three, six, and twelve months post-surgery, with imaging studies at three and six months to screen for regional lymph node enlargement or distant metastatic disease. Thoracic radiographs and abdominal ultrasound are the standard imaging modalities used for surveillance. Any clinical signs suggestive of recurrence or metastasis, such as weight loss, lethargy, or the development of new masses, should prompt immediate veterinary evaluation.

For dogs presenting with paraneoplastic syndromes, particularly hyperestrogenism and bone marrow suppression, follow-up monitoring focuses on the resolution of hormonal effects and recovery of hematopoietic function. Serial complete blood counts should be performed at weekly to biweekly intervals until all cell lines have normalized. Dermatological changes including alopecia and hyperpigmentation resolve gradually over several months, and owners should be counseled that full hair regrowth may take three to six months or longer.

Prevention of testicular neoplasms centers on elective castration, which eliminates the risk entirely by removing the target organ. For intact males maintained for breeding or other purposes, regular veterinary examinations with specific attention to testicular palpation, combined with owner education about self-examination techniques, represent the best strategies for early detection. Annual or semiannual testicular ultrasound may be considered for high-risk breeds or older intact males.

Breeding program management should incorporate awareness of the heritable nature of cryptorchidism and breed predispositions to testicular neoplasia. Breeders should maintain accurate health records, avoid breeding cryptorchid dogs or known carriers of the cryptorchidism gene, and consider the overall incidence of testicular tumors within their breeding lines when making selection decisions. Genetic research continues to advance toward the development of screening tools that may eventually allow identification of dogs at increased genetic risk for testicular neoplasia before tumors develop.